Prevention of vertebral fractures by strontium ranelate in postmenopausal women with osteoporosis

Osteoporosis International

Volumn 16, Issue SUPPL. 1, 2005, Pages

  Compston, Juliet ^a,b  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Postmenopausal osteoporosis; Strontium ranelate; Vertebral fracture

Indexed keywords

CALCIUM; STRONTIUM RANELATE; VITAMIN D;

ADULT; AGED; BACKACHE; BODY HEIGHT; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE EXACERBATION; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; FRAGILITY FRACTURE; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; VERTEBRA FRACTURE; VITAMIN SUPPLEMENTATION;

AGED; BONE RESORPTION; CALCIUM, DIETARY; DIETARY SUPPLEMENTS; FEMALE; HUMANS; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; OSTEOPOROSIS, POSTMENOPAUSAL; RANDOMIZED CONTROLLED TRIALS; SPINAL FRACTURES; THIOPHENES; UNCOUPLING AGENTS; VITAMIN D;

EID: 20044391081     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-004-1760-9     Document Type: Review

References (17)

1. Boivin G, Deloffre P, Perrat B, Panczer G, Boudeulle M, Tsouderos Y, et al (1996) Strontium distribution and interactions with bone mineral in monkey iliac bone after strontium salt (S12911) administration. J Bone Miner Res 11:1302-1311
2. Su Y, Bonnet J, Deloffre P, Tsouderos Y, Baron R (1992) The strontium salt S12911 inhibits bone resorption in mouse calvaria and isolated rat osteoclast cultures. Bone Miner 17 [Suppl]:188
3. Canalis E, Hott M, Deloffre P, Tsouderos Y, Marie PJ (1996) The divalent strontium salt S12911 enhances bone cell replication and bone formation in vitro. Bone 18:517-523
4. Marie PJ, Hott M, Modrowski D, de Pollak C, Guillemain J, Deloffre P, et al (1993) An uncoupling agent containing strontium prevents bone loss by depressing bone resorption and maintaining bone formation in estrogen-deficient rats. J Bone Miner Res 8:607-615
5. Buehler J, Chappuis P, Saffar JL, Tsouderos Y, Vignery A (2001) Strontium ranelate inhibits bone resorption while maintaining bone formation in alveolar bone in monkeys (Macaca fascicularis). Bone 29:176-179
6. Meunier PJ, Slosman DO, Delmas PD, Sebert JL, Brandi ML, Albanese C, et al (2002) Strontium ranelate: dose-dependent effects in established postmenopausal vertebral osteoporosis - a 2-year randomised placebo controlled trial. J Clin Endocrinol Metab 87:2060-2066
7. Meunier PJ, Roux C, Seeman E, Ortolani S, Badurski JE, Spector TD, et al (2004) The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N Engl J Med 350:459-468
8. Genant HK, Wu CY, van Kuijk C, Nevitt MC (1993) Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 9:1137-1148
9. Black DM, Cummings SR, Karpf DB, Cauley JA, Thompson DE, Nevitt MC, et al (1996) Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet 348:1535-1541
10. Harris ST, Watts NB, Genant HK, McKeever CD, Hangartner T, Keller M, et al (1999) Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis. A randomized controlled trial. JAMA 282:1344-1352
11. Ettinger B, Black DM, Mitlak BH, Knickerbocker RK, Nickelsen T, Genant HK, et al (1999) Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. JAMA 282:637-645
12. Reginster J-Y, Minne HW, Sorensen OH, Hooper M, Roux C, Brandi ML, et al (2000) Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Osteoporos Int 11:83-91
13. Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster J-Y, et al (2001) Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344:1434-1441
14. Ross PD, Genant HK, Davis JW, Miller PD, Wasnich RD (1993) Predicting vertebral fracture incidence from prevalent fractures and bone density among non-black osteoporotic women. Osteoporos Int 3:120-126
15. Klotzbuecher CM, Ross PD, Landsman PB, Abbott TA III, Berger M (2000) Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res 15:721-739
16. Lindsay R, Silverman SL, Cooper C, Hanley DA, Barton I, Broy SB, et al (2001) Risk of new vertebral fracture in the year following a fracture. JAMA 285:320-323
17. Maricic M, Adachi JD, Sarkar S, Wu W, Wong M, Harper KD (2002) Early effects of raloxifene on clinical vertebral fractures at 12 months in postmenopausal women. Arch Intern Med 162:1140-1143